YD Bio 1H FY26 net income swings to USD 6.7 million; revenue rises 315% to USD 846,501 - YDES News | RalliesYD Bio 1H FY26 net income swings to USD 6.7 million; revenue rises 315% to USD 846,501
Y
YDES• First-half FY26 results and operating update
- YD Bio posted net income of US$6.7 million as revenue climbed 315% to US$846,501 in the six months ended June 30, 2026.
- Operating loss widened 66% to US$3.23 million as total operating expenses rose 73% to US$3.5 million.
- Other income surged to US$9.93 million, driven by a US$9.85 million change in fair value of warrant liabilities.
- Cash fell to US$2.66 million at June 30, 2026 from US$6.01 million at Dec. 31, 2025.
- Management highlighted scaling a 47-state lab footprint, a Canadian OkaiDx pilot, and scaled-up exosome manufacturing batches.
TBN
•
